Cargando…
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project
Orally administered direct-acting antivirals (DAAs) have dramatically changed the possibility of curing HCV (hepatitis C virus) infection, with the two principal HCV regimens based on the combination of glecaprevir + pibrentasvir (GLE-PIB) and sofosbuvir + velpatasvir (SOF-VEL). A combination of dru...
Autores principales: | Borghi, Claudio, Ciancio, Alessia, Gentile, Ivan, Perrone Filardi, Pasquale, Pasqualetti, Patrizio, Brillanti, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737105/ https://www.ncbi.nlm.nih.gov/pubmed/36498521 http://dx.doi.org/10.3390/jcm11236946 |
Ejemplares similares
-
The “Early Treatment” Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique
por: Russo, Giuseppina, et al.
Publicado: (2021) -
Renal protection in chronic heart failure: focus on sacubitril/valsartan
por: Pontremoli, Roberto, et al.
Publicado: (2021) -
Early management of COPD: where are we now and where do we go from here? A Delphi consensus project
por: Di Marco, Fabiano, et al.
Publicado: (2019) -
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs
por: Paolucci, Stefania, et al.
Publicado: (2017) -
Recommendations for effective documentation in regional anesthesia: an expert panel Delphi consensus project
por: Ahmed, Hassan M, et al.
Publicado: (2022)